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same phenomenon. The analysis allows a better under-
standing of how symptom improvements are reﬂected 
in patients’ well-being. It also enables meaningful health
economic analysis in situations using clinical data sources
to be conducted.
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Skin diseases have a strong impact on the physical and
mental well-being of the patient. It is clear that dermato-
logical diseases affect not only the life of the children but
also that of his/her family. OBJECTIVES: The Avène 
dermatological hydrotherapy center (DHC), welcomes
over 2500 patients a year suffering from skin diseases.
The objective of the study is to demonstrate the relevance
of the long-term effects of hydrotherapy cares (HC) on
patients’ quality of life. METHODS: A generic scale (SF-
12), a speciﬁc scale (DLQI—dermatology life quality
index) and the consequences upon diurnal somnolence
(Epworth scale) are completed by each patient at their
arrival at the Avène DHC (inclusion), at the end of 
HC-three weeks- and at three and six months. The com-
pleted questionnaires were returned by post. RESULTS:
In this ﬁrst analysis, patients suffering from the three fol-
lowing conditions, psoriasis, atopic dermatitis and burns,
were taken into account and analysed at inclusion and at
the end of the HC. The DLQI score at inclusion is 31.5.
At the end of HC, the DLQI score is 11.67. These ﬁrst
results show evidence of an improvement of patients’
QoL after three weeks of HC (p < 0,001). Concerning the
SF-12, the results consisted of two scores: mental (MCS-
12) and physical (PCS-12). At inclusion the patients
scores were: pcs-12 = 48 & mcs-12 = 35. At the end of
HC, the scores were: PCS-12 = 47 & MCS-12 = 42. These
results demonstrated a QoL improvement for the mental
health dimension of the SF-12 (p < 0.02). For the pcs-12
the difference was not signiﬁcant. There were no statisti-
cally signiﬁcant change in patients’ consequences upon
diurnal somnolence at the end of the HC. CONCLU-
SION: These ﬁrst results show evidence of an improve-
ment of patients’ QoL after three weeks of HC. It will
really be relevant to try to conﬁrm the timelessness of this
QoL improvement at three and six months.
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Skin diseases have a strong impact on the physical and
mental well-being of the patient. This is conﬁrmed by the
large number of quality of life studies that exist. It is clear
that dermatological diseases affect not only the life of the
children but also that of his/her family. OBJECTIVES:
The Avène Dermatological Hydrotherapy Center, which
welcomes over 2500 patients a year, treats an increasing
number of children. In most of case, at least one of the
parents is present during the hydrotherapy treatments.
For a better understanding of the repercussions of the skin
disease, we also wanted to assess the quality of life of the
parents. METHOD: A generic scale (SF12) and the con-
sequences upon diurnal somnolence (Epworth scale) are
completed by the accompanying parent, over a sufﬁ-
ciently long period of time and at regular intervals (Inclu-
sion, 3 weeks -end of hydrotherapy cares-, 3 and 6
months). The completed questionnaires were returned by
post. RESULTS: The results consisted of 2 scores: mental
(MCS-12) and physical (PCS-12). The norm observed in
a standard American population is 50 each dimension. 
At inclusion, the parents’ scores were: PCS-12 = 53 and
MCS-12 = 42, showing evidence of a low quality of life
score in the mental health dimension compared to the
standard American population. This parents’ quality of
life score can be compare to the adults patient’s quality
of life score assessed in similar condition. For example
their mental health dimension score is equivalent to 
the mental health score of the spouses of patients suffer-
ing from benign prostatic hyperplasia. CONCLUSION:
Those preliminary results show evidence of the impact on
their children dermatologic disease on the parents’ quality
of life. Thus appropriate disease management and any
treatment which help to reduce the dermatological symp-
toms of the children could improve their parents’ quality
of life.
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OBJECTIVE: To evaluate quality of life consequences 
for patients with psoriasis in Spain. METHOD: 6.000
anonymous questionnaires were sent, via a Psoriasis
Patient Support Group (Acción Psoriasis). The question-
naires contained 2 scales: the Psoriasis Disability Index
(PDI) plus 10 questions concerning treatment and evolu-
tion of the patients’ psoriasis RESULTS: One thousand
nine hundred questionnaires were returned (June 2002):
response rate 42%. An analysis of the ﬁrst 810 question-
naires was realised. The sex ratio Men (M)/Women (W)
was: 49/51. Mean age: 42 years. Mean age of diagnosis:
21,8 years. The average to the total score was 8.47 (sd:
7.2 rank 0 to 39) i.e. 18.82 (sd: 17.2) when reported to
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a scale of 0 to 100. Signiﬁcative difference was observed
between M and W for the global handicap score 20.73
vs 16,95 p < 0,002. Two groups were identiﬁed: ﬂare-up
of psoriasis (84%), psoriasis not in ﬂare-up (12%)—no
answers (4%)- Psoriasis had a greater affect on patients
with episode: PDI score = 20,24 (sd 17,52) than the
patient without episode PDI score = 8.98 (sd 11,34). This
difference was signiﬁcant p < 0.00001. CONCLUSION:
These results highlight the value of appropriate and rele-
vant psychological and medical environment for patient
suffering from psoriasis.
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OBJECTIVE: To evaluate the effect of psoriasis on
quality of life of patients and DS in France. To highlight
a relation between DS and quality of life for patients suf-
fering from psoriasis. METHOD: Seven hundred ﬁfty
anonymous questionnaires (comprised two scales: the
Psoriasis Disability Index [PDI] and the Center for Epi-
demiologic Studies—Depression scale [CES-D] were sent,
via a Psoriasis Patient Support Group (APLCP). The CES-
D, a short self-report scale composed of 20 items is a
questionnaire designed to measure DS in the general pop-
ulation. The CES-D is widely used in epidemiological
surveys on large populations. The PDI is a questionnaire
speciﬁc for psoriasis patients. RESULTS: 297 question-
naires were returned (June 2002): response rate 39.6%.
The sex ratio Men (M)/Women (W) was 47/53. Mean
age: 48.8 years. Mean age of diagnosis: 26.3 years. The
average to the total PDI score was 10.3 (s.d: 7.7 rank 0
to 39) i.e 22.8 (sd: 17.10) when reported to a scale of 0
to 100. Signiﬁcant difference was observed between W
and M for the global handicap score 24.53 vs 19.87 p <
0.02. Two groups were identiﬁed: ﬂare-up of psoriasis
(49.5%), psoriasis not in ﬂare-up (48%)—no answers
(2.5%)—Psoriasis had a greater affect on patients with
episode: PDI score = 24.9 (s.d: 17.02) than patient
without episode: PDI score = 20.27 (s.d: 16.91). This dif-
ference was signiﬁcant (p < 0.05). In the studied popula-
tion, 44.6% of the patients reported DS (CES-D+)
whereas 55.4% did not (CES-D-). In CES-D+ patients the
PDI score = 30.98 (sd: 18.28) was higher than the score
in CES-D-patients: PDI score = 16.43 (sd: 13.97). This
difference was signiﬁcant (p < 2.10–11). CONCLUSION:
Patients in a current ﬂare-up of psoriasis are more
affected and feel more disabled in their daily life (higher
disability score and higher frequency of DS) compared to
patients without episode. Patients with DS (CES-D+),
reported a higher impact of their psoriasis on their quality
of life (PDI score 30.98 versus 16.43).
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The Dermatology Life Quality Index (DLQI) was
designed to be used with different types of dermatologic
pathologies instead of being directed at a single condi-
tion such as psoriasis or acne. Although a reasonable
approach, this broader measurement model may not be
appropriate for conditions such as chronic idiopathic
urticaria (CIU) that, unlike some other chronic skin con-
ditions, are subject to daily or weekly ﬂuctuations.
OBJECTIVES: This validation study tested the reliability,
structural validity, and construct validity of the DLQI in
two samples of CIU patients obtained from two large
identical multicenter, double-blind, randomized, placebo-
controlled, parallel studies. METHODS: Patients
recorded daily signs and symptoms (# of wheals and 
pruritus severity) on a daily basis, and completed the
DLQI during three clinic visits (approximately 2 weeks
apart); investigators also assessed CIU severity.
RESULTS: The DLQI means and standard deviations
indicated relatively symmetrical distributions free from
serious ceiling or ﬂoor effects, and alpha coefﬁcients indi-
cated an acceptable level of reliability in the two samples.
The exploratory factor analysis suggested that the six cat-
egories of items did not deﬁne different factors and sup-
ported the unidimensionality of the scale. In a formal test
of the structural validity for a single-factor model, con-
ﬁrmatory factor analysis supported either a one or two-
factor model, with the correlations from the two-factor
model indicating that the total score of all items is inter-
pretable as a global score. Item response analyses showed
that most items were able to distinguish people with 
low versus high impairment at the appropriate ends of 
the continuum demonstrating content validity. Finally,
changes in DLQI scores were related to changes in inves-
tigator and patient-assessed symptoms of urticaria, pro-
viding evidence of construct validity. CONCLUSION:
These results support the DLQI as a valid instrument for
the measurement of CIU related quality of life.
PES26
HEALTH STATE UTILITIES IN PATIENTS WITH
DERMATOLOGICAL PROBLEMS—A
POPULATION STUDY
Bingefors C1, Isacson D1, Lindberg M2
1Uppsala University, Uppsala, Sweden; 2Karolinska Institute,
Stockholm, Sweden
OBJECTIVES: In spite of the common occurrence of der-
matological problems there are virtually no population-
based studies on the impact of skin diseases in the
